Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27544253 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL2128094 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL6310117 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7528671 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7623899 | 0.96 | SLC34A1 (0.75) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7530569 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL2954685 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL5907878 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL2127340 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL5293558 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113045774-B | Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof | 江汉大学 | 2022-05-13 | — | — | CN | claimed |
| CN-114031791-A | Multi-response color-changing hydrogel and preparation method and application thereof | 长春工业大学 | 2022-02-11 | — | — | CN | claimed |
| CN-113045774-A | Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof | 江汉大学 | 2021-06-29 | — | — | CN | claimed |
| CN-101881750-A | Microchip detector of content of arteannuin in Artemisia apiacea and method thereof | UNIV CHONGQING | 2010-11-10 | — | — | CN | claimed |
| EP-0231816-B1 | PHARMACEUTICAL PREPARATIONS FOR THE STABILIZATION OF INTERFERON ALPHA | Dr. Karl Thomae GmbH (DE) | 1991-05-29 | — | — | EP | claimed |
| US-4290910-A | CONTROLLING PH, AMINE, BUFFER | TANABE SEIYAKU CO., LTD. (JP) | 1981-09-22 | — | — | US | claimed |
| CN-116924928-A | Preparation method of aliskiren intermediate | 江苏阿尔法药业股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-113045774-B | Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof | 江汉大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-110398548-B | High performance liquid chromatography separation and determination method for related impurities in fosfomycin trometamol raw material medicine and preparation thereof and application | 山西仟源医药集团股份有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-114031791-A | Multi-response color-changing hydrogel and preparation method and application thereof | 长春工业大学 | 2022-02-11 | — | — | CN | disclosed |
| CN-113045774-A | Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof | 江汉大学 | 2021-06-29 | — | — | CN | disclosed |
| CN-107753481-B | A pharmaceutical composition containing buffer for treating cancer | 沈阳药科大学 | 2021-01-15 | — | — | CN | disclosed |
| CN-110398548-A | The high performance liquid chromatography separation measuring method and application of relative substance in a kind of fosfomycin trometamol bulk pharmaceutical chemicals and its preparation | SHANXI C&Y PHARMACEUTICAL GROUP CO LTD | 2019-11-01 | — | — | CN | disclosed |
| CN-101881750-A | Microchip detector of content of arteannuin in Artemisia apiacea and method thereof | UNIV CHONGQING | 2010-11-10 | — | — | CN | disclosed |
| US-20060166337-A1 | Process for producing optically active erythro 3-cyclohexylserines | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1666458-A1 | OPTICALLY ACTIVE 3,3 -DITHIOBIS(2-AMINO-2-METHYLPROPIONI C ACID) DERIVATIVE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-AMINO-3-MERCAPTO-2-METHYL-PROPIONIC ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2006-06-07 | — | — | EP | disclosed |
| EP-1538216-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ERYTHRO 3-CYCLOHEXYLSERINES | Nippon Kayaku Kabushiki Kaisha (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-6046018-A | Highly sensitive method for assaying chiro-inositol and compositions for the assay | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2000-04-04 | — | — | US | disclosed |
| EP-0969098-A1 | HIGHLY SENSITIVE METHOD FOR ASSAYING CHIRO-INOSITOL AND COMPOSITIONS FOR THE ASSAY | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 2000-01-05 | — | — | EP | disclosed |
| US-4290910-A | CONTROLLING PH, AMINE, BUFFER | TANABE SEIYAKU CO., LTD. (JP) | 1981-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060166337-A1 | Process for producing optically active erythro 3-cyclohexylserines | AARS1, ALAD, ALDH7A1 | SLC34A1 2792/4885KDM4E 873/4885CYP2C19 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.